Kidney Transplant; Complications Clinical Trial
Official title:
Evaluation of Intima and Media Layer of Iliac and Renal Artery to Verify a Mechanism of Intracranial Aneurysm Development in Autosomal Dominant Polycystic Kidney Disease Patients
ADPKD is the most common form of hereditary kidney disease and is known to occur in 1 of 400
to 1000 population in the U.S. ADPKD consists of 2.8% of patients receiving kidney
transplantation in our center. It is known that ADPKD is associated with vascular anomalies,
including abdominal aneurysms, valvular anomalies and especially intracranial aneurysms.
Intracranial aneurysms occur in 9~12% of the ADPKD population which is higher than 2~3% in
the general population and is known to be associated with PKD1 or PKD2 heritage.
Until now, most of the studies regarding intracranial aneurysms in ADPKD are conducted in
animal models, and there are only few cellular studies conducted from human samples. While
performing kidney transplantation to ESRD ADPKD patients, arterial tissues from nephrectomy
specimens can be obtained. The objective of this study is to investigate the mechanism of
intracranial aneurysm in ADPKD patients by analyzing iliac and renal artery characteristics.
ADPKD is associated with PKD1 gene on chromosome 16 and PKD2 gene on chromosome 4 and these
gene respectively code polycystin 1 and polycystin 2. Currently the hypotheses for increased
intracranial aneurysm rate in ADPKD patients is that mutation of polycystin is not only
confined to nephron tissues but also in endothelial cells and vascular smooth muscle cells
and results in mutation of vascular phenotype. Also recent studies show polycystin complex
causes cystic changes through mutation in primary cilia in renal epithelium. Wild type
endothelial cells respond to fluid shear stress by regulating levels of intracellular calcium
and nitric oxide, however, PKD1 or PKD2 mutation in fetal aortic endothelial cells revealed
loss of these responses.
During kidney transplantation, bilateral nephrectomies are routinely performed to ADPKD
patients. In this study, blood, urine, iliac artery and renal artery tissues will be
collected from ADPKD patients receiving kidney transplantation to analyze the arterial
characteristic and gene mutation of ADPKD patients. The aim of this study is to evaluate
mechanisms associated with intracranial aneurysm occurence in ADPKD patients by analyzing the
genetic mutation and vascular deformities of these patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04369456 -
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
|
N/A | |
Recruiting |
NCT06001320 -
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
|
Early Phase 1 | |
Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
Not yet recruiting |
NCT05782543 -
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
|
N/A | |
Completed |
NCT03996551 -
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
|
N/A | |
Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
Recruiting |
NCT04508907 -
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
|
Phase 4 | |
Recruiting |
NCT06440330 -
Define Predictors for Posttransplant Diabetes Mellitus Study
|
||
Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
Recruiting |
NCT04713774 -
Bone Density and Vascular Calcifications Evolution After Renal Transplant
|
||
Active, not recruiting |
NCT05483725 -
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
|
||
Recruiting |
NCT06095492 -
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
|
N/A | |
Active, not recruiting |
NCT04207177 -
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
|
Phase 4 | |
Recruiting |
NCT03410654 -
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
|
Early Phase 1 | |
Completed |
NCT03373266 -
Serun Fluoride and Kidney Transplant
|
Phase 2 | |
Completed |
NCT04835948 -
Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation
|
||
Not yet recruiting |
NCT04514666 -
VOCs in Kidney and Liver Transplants
|
N/A | |
Recruiting |
NCT03373500 -
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
|
N/A | |
Recruiting |
NCT05900401 -
Delayed Tolerance Through Mixed Chimerism
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05166460 -
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation
|
N/A |